The recent novel Coronavirus (COVID-19) outbreak in 2019 has led to the use of several types of swabs, media, and kits to test the collected samples for COVID-19. The CDC guidelines for the collection and handling of clinical specimens suspected of Coronavirus Disease 2019 (COVID-19) mentions that health workers should only use synthetic fiber swabs with plastic shafts. The CDC recommends collection of only the nasopharyngeal (NP) swab for Coronavirus Disease 2019 (COVID-19). OP- oropharyngeal swabs remain an acceptable specimen type. NP swabs can be utilized to test asymptomatic persons. Increase in COVID-19 testing, globally, requires a safe and easy sample collection and transport mechanism.
Rising geriatric population
The global geriatric population continues to increase at an unprecedented rate. Presently, 8.5% of people across the world (617 million) are aged 65 and over. According to a new report – An Aging World: 2015, the percentage is projected to jump to nearly 17% of the world’s population by 2050 (1.6 billion). According to the National Institutes of Health, the population aged 65 and over in the U.S. is anticipated to nearly double in the next three decades, from 48 million to 88 million by 2050. The global population aged 80 and older is expected to more than triple between 2015 and 2050, from 126.5 million to 446.6 million. The population aged 80 and older in some countries in Asia and Latin America is likely to quadruple by 2050.
Increase in prevalence of COVID-19
According to Spandidos Publications 2020- Molecular Medicine Reports, the global spread of COVID?19 can be described as the worst pandemic in humanity in the last century. To date, COVID?19 has infected more than 3,000,000 people worldwide and killed more than 200,000 people. Obese patients are at a higher risk of hospital admission regardless of their viral status. Furthermore, obese patients are at a higher risk of hospitalization as compared to normo-ponderal ones, when affected by influenza. The World Health Organization (WHO) has characterized both the COVID-19 outbreak and obesity ‘epidemic’ as international public health emergencies. Global clinical and epidemiological observations confirm that CoVs can cause more severe symptoms and complications in people with obesity-related conditions. According to WHO World Health Organization, on March 19, 2020, 209 839 (16 556) confirmed COVID-19 cases and 8778 deaths (828) were recorded.
The global COVID-19 sample collection kits market is highly consolidated owing to the presence of a number of key players. Leading players operating in the global COVID-19 sample collection kits market include:
Global COVID-19 Sample Collection Kits Market, by Product
Global COVID-19 Sample Collection Kits Market, by Application
Global COVID-19 Sample Collection Kits Market, by End-user
Global COVID-19 Sample Collection Kits Market, by Region
Interested in this report?
Get a FREE Brochure now!
*Get Brochure (PDF) sent to your email within minutes
Complete the form below and we'll get back to you shortly.